Cyclic compounds (1)
CHRYSENE (65996-93-2, 50-32-8, 218-01-9)
Chrysene is a polycyclic aromatic hydrocarbon (PAH) with the molecular formula C 18H 12 that consists of four fused benzene rings. It is a natural constituent of coal tar, from which it was first isolated and characterized. It is also found in creosote at levels of 0.5-6 mg/kg.
TCDD · PCDD · Tetrachlorodibenzodioxin
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a polychlorinated dibenzo-p-dioxin (sometimes shortened, though inaccurately, to simply "dioxin") with the chemical formula C 12H 4Cl 4O 2. TCDD is a colorless solid with no distinguishable odor at room temperature. It is usually formed as a side product in organic synthesis and burning of organic materials.
1-METHYLNAPHTHALENE (90-12-0, 1321-94-4)
1-Methylnaphthalene is a polycyclic aromatic hydrocarbon (PAH). It has a cetane number of zero, and was previously used as the lower reference for cetane number. However, due to the expense and handling difficulty of 1-methylnaphthalene, it was replaced in this capacity by isocetane, with a CN of 15.
Pentachloroethane is a non-flammable but toxic chemical compound of chlorine, hydrogen, and carbon. It is used as a solvent for oil and grease, in metal cleaning, and in the separation of coal from impurities.
perchloroethane · carbon hexachloride · Avlothane
Hexachloroethane, also known as perchloroethane (PCA), C2Cl6, is a white crystalline solid at room temperature with a camphor-like odor. It has been used by the military in smoke compositions, such as base-eject smoke munitions (smoke grenades).
1-Phenyltridecane (123-02-4, 68648-87-3, 129813-59-8, 29463-64-7)
A 215 · A-215 · alkylate-215
FLUORENE (2299-68-5, 86-73-7)
Fluorene , or 9H-fluorene, is a polycyclic aromatic hydrocarbon. It forms white crystals that exhibit a characteristic, aromatic odor similar to that of naphthalene. It is combustible.
Tasosartan is an angiotensin II receptor antagonist. It was withdrawn from FDA review by the manufacturer after phase III clinical trials showed elevated transaminases (a sign of possible liver toxicity) in a significant number of participants given the drug.